Christine Blank, Contributing Editor
Contributing Editor Christine Blank is a freelance writer based in Florida.
Muscular dystrophy drug launch halts after pricing concerns
Marathon Pharmaceuticals is temporarily pausing the launch of its drug to treat a rare form of muscular dystrophy (MD) after concerns over its $89,000 price tag.
New bladder cancer, kidney disease therapies available
FDA recently approved 2 new therapies: an expanded drug indication for locally advanced or metastatic urothelial carcinoma (mUC) and a treatment for secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.
Major allergic reactions linked to common antiseptics
FDA is warning about rare but serious allergic reactions have from the widely-used skin antiseptic products containing chlorhexidine gluconate.
Diabetic patients challenge insulin makers
In the latest flap over the high cost of drugs, diabetes patients filed a class-action lawsuit against insulin makers.
Will Trump’s FDA picks speed drug approvals?
Three candidates that President Donald Trump is considering for FDA Commissioner are likely to speed drug approvals, analysts say.
First therapy approved for rare blood cancer
FDA recently granted accelerated approved for ibrutinib (Imbruvica, Janssen, Pharmacyclics), the first treatment for patients with a certain type of lymphoma.
Senator, NABP Call for Better Detection of Drug Interaction After Chicago Investigation
Senator Durbin and NABP call for new pharmacy safety policies in aftermath of Chicogo Tribune investigation.
Top 5 Things to Know About Future Drug Spending
How will money be spent on medications in the next 5 years? Here's a look at the top trends.
Drug distributor pays record fine
McKesson Corp., one of the largest distributors of pharmaceuticals, agreed to pay a record civil penalty for alleged violations of the Controlled Substances Act.
How You Can Help Prevent Opioid Abuse
Pharmacists are on the front lines of helping to curb abuse and misuse in the opioid epidemic. But how can you make this happen in the real world?